Topical acyclovir for genital herpes.

[1]  K. Holmes,et al.  Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. , 1982, The American journal of medicine.

[2]  J. Luby.  Therapy in genital herpes. , 1982, The New England journal of medicine.

[3]  K. Holmes,et al.  A trial of topical acyclovir in genital herpes simplex virus infections. , 1982, The New England journal of medicine.

[4]  D. Mayo.  Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine , 1982, Journal of clinical microbiology.

[5]  N. Flournoy,et al.  Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. , 1982, Annals of internal medicine.

[6]  O. Laskin,et al.  ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY , 1982, The Lancet.

[7]  C. Crumpacker,et al.  Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. , 1982, The New England journal of medicine.

[8]  K. Holmes,et al.  Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. , 1981, The New England journal of medicine.

[9]  C. Wilfert,et al.  1072 ALTERED PATHOGENICITY OF ACYCLOVIR (ACV) RESISTANT HSV FROM AN IMMUNODEFICIENT CHILD , 1981, Pediatric Research.

[10]  R. T. Walker,et al.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. , 1980, The Journal of infectious diseases.

[11]  H. Field,et al.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo , 1980, Antimicrobial Agents and Chemotherapy.

[12]  W. E. Josey,et al.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. , 1970, American journal of epidemiology.